Ocular Genetic Diagnostic Market

There are around 5,000 genetic disorders and syndromes that affect the mankind. Of this vast number, at least one third of them are related to eyes. With the recent advancements in molecular genetics and various sequencing methods, a wide array of various hereditary eye diseases have been discovered.
Ocular Genetic Diagnostic Market aims to provide a comprehensive presentation of the global market for Ocular Genetic Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Genetic Diagnostic. Ocular Genetic Diagnostic Market contains market size and forecasts of Ocular Genetic Diagnostic in global, including the following market information:
Global Ocular Genetic Diagnostic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Ocular Genetic Diagnostic market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Next-generation Sequencing (NGS) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ocular Genetic Diagnostic include Quest Diagnostics, Columbia ophthalmology, Centogene, DBGen, Medgenome, Sankara Nethralaya, Fulgent Genetics, GeneDx and Devyser, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ocular Genetic Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ocular Genetic Diagnostic Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Ocular Genetic Diagnostic Market Segment Percentages, by Type, 2022 (%)
Next-generation Sequencing (NGS)
Multiplex Ligation-Dependent Probe Amplification (MLPA)
Fragment Analysis PCR for Repeat Expansion Analysis
Global Ocular Genetic Diagnostic Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Ocular Genetic Diagnostic Market Segment Percentages, by Application, 2022 (%)
Hospitals
Diagnostic Laboratories
Academic and Research Centers
Others
Global Ocular Genetic Diagnostic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Ocular Genetic Diagnostic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ocular Genetic Diagnostic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Ocular Genetic Diagnostic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Quest Diagnostics
Columbia ophthalmology
Centogene
DBGen
Medgenome
Sankara Nethralaya
Fulgent Genetics
GeneDx
Devyser
Invitae Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ocular Genetic Diagnostic, market overview.
Chapter 2: Global Ocular Genetic Diagnostic market size in revenue.
Chapter 3: Detailed analysis of Ocular Genetic Diagnostic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ocular Genetic Diagnostic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.